All Posts: clinical trials
32 Articles
- News Release
Clinical Study Deepens Understanding of Mesothelioma and Opens the Door to Potential Treatment Options
People with operable diffuse pleural mesothelioma may benefit from immunotherapy before and after surgery, based on results of a clinical trial exploring the sequence of…
September 8, 2025
- News Release
Investigational Drug Shows Promise in a Clinical Trial for Lung Cancers With ALK Mutations
Early signals from phase 1 of the ALKOVE-1 clinical trial suggest potential benefit from the use of an investigational drug called NVL-655 in people whose non-small cell lung…
November 8, 2024
- GUMC Stories
ISPY2: A Unique, Flexible Breast Cancer Trial for Modern Times
The ISPY2 breast cancer clinical trial is a unique phase 2 study that offers a broad range of treatment options for patients with locally advanced breast.…
August 16, 2024
- News Release
Experimental Therapy Shows Promise in Pancreatic Cancer Clinical Trial
Clinicians at Georgetown University’s Lombardi Comprehensive Cancer Center reported promising preliminary findings based on outcomes in the first six patients with metastatic…
June 1, 2024
- News Release
The Aspirin Conundrum: Navigating Negative Results, Age, Aging Dynamics and Equity
A new study examining the role of aspirin in breast cancer treatment reveals critical issues related to health equity and aging that have broad implications for cancer and other…
April 29, 2024
- News Release
Georgetown Study Explores THC/CBD Combination to Reduce Dementia-related Agitation at the End of Life
In a first-of-its-kind clinical trial, the Georgetown University Medical Center Memory Disorders Program will study the effects of an oral drug called T2:C100, which is comprised…
February 8, 2024
- GUMC Stories
Understanding Immunotherapy Resistance Leads to New Therapeutic Strategies — and Hope
Samir Khleif, MD, an immunologist and professor of oncology at Georgetown Lombardi, is working to understand why some cancers become resistant to immunotherapy, and how that…
January 18, 2024
- News Release
New Study Finds Personalized mRNA Vaccine Given with Immunotherapy Reduces Recurrence in High-Risk Melanoma Patients
A new study conducted by an international team of researchers, including clinical investigators at Georgetown Lombardi and John Theurer Cancer Center, demonstrates that a…
April 28, 2023
- GUMC Stories
Ruesch Symposium Participants Encourage Patients to Consider Clinical Trials
Held by the Ruesch Center for the Cure of Gastrointestinal Cancers at Georgetown Lombardi Comprehensive Cancer Center, the Ruesch Symposium brings together researchers,,…
December 4, 2022
